CMS 2020 Final Hospital Outpatient Rule Allows Reimbursement of PCI in Ambulatory Centers
November 1, 2019—The American College of Cardiology (ACC) announced that the Centers for Medicare and Medicaid Services (CMS) will release the 2020 Medicare Physician Fee Schedule final rule addressing Medicare payment and quality provisions for physicians in 2020, under which, physicians will see a virtually flat conversion factor on January 1, 2020, going from $36.04 to $36.09. The final version of the document is scheduled to be published on November 15, 2019.
CMS estimates that the physician rule will maintain overall payment to cardiologists from 2019 to 2020 through updates to work, practice expense, and malpractice relative value units. This estimate is based on the entire cardiology profession and can vary widely depending on the mix of services provided in a practice. In July, the ACC announced the release of the proposed 2020 fee schedule and outpatient rules and presented a summary of the document.
Among the many items addressed in the final document, the ACC highlighted that the hospital outpatient rule includes the addition of CPT codes describing angioplasty and percutaneous coronary interventions with stenting to the Ambulatory Surgery Center Covered Procedures list for 2020, reflecting the feedback of ACC and other stakeholders, noted the society.
In addition to the Physician Fee Schedule, the 2020 Hospital Outpatient Prospective Payment System final rule is scheduled to be published on November 12, 2019. The outpatient rule indicates a 2.6% payment update for hospitals and other proposals.
The CMS fact sheet is available online here: Finalized Policy, Payment, and Quality Provisions Changes to the Medicare Physician Fee Schedule for Calendar Year 2020. ACC also posted online the CMS 2020 Quality Payment Program Final Rule Overview Fact Sheet.
advertisement
Related Articles
Top 5 Articles From October 2019
Meeting the Challenge…
By Azeem Latib, MD
Massive Thromboembolism, PFO, and Acute Limb Ischemia
By Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD
Radial Access for the Evaluation of Bypass Grafts
By Moderator: Mirvat Alasnag, MD, FACP, FSCAI, FRCP
Panelists: James Nolan, MBChB, FRCP, MD; Sunil Rao, MD; and Binita Shah, MD, MS, FACC, FSCAI
Compensation and Production Trends for Interventionalists
A look at MedAxiom’s annual report reflecting the continued evolution of the field in terms of physician demand and compensation agreements.
By Joel Sauer, MBA
TAVR in Small Anatomy
By Moderator: Matias Sztejfman, MD
Panelists: Guilherme Attizzani, MD; Cristian Baeza, MD; Hemal Gada, MD, MBA; Anthony Main, MD; and Henrique Barbosa Ribeiro, MD, PhD
Top 5 from EVToday's Current Issue
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
